We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
30 hedge funds and large institutions have $83.5M invested in Crescent Biopharma in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
5% more capital invested
Capital invested by funds: $79.3M → $83.5M (+$4.16M)
3% more funds holding
Funds holding: 29 → 30 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Holders
30
Holders Change
+1
Holders Change %
+3.45%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
6
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$853K |
| 2 |
Goldman Sachs
New York
|
-$146K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$143K |
| 4 |
SIM
Spark Investment Management
New York
|
-$123K |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$51.8K |
